In the last trading session, 15.53 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 1.24. With the company’s per share price at $30.85 changed hands at -$1.37 or -4.25% during last session, the market valuation stood at $7.16B. HIMS’s last price was a discount, traded about -13.52% off its 52-week high of $35.02. The share price had its 52-week low at $8.09, which suggests the last value was 73.78% up since then. When we look at Hims & Hers Health Inc’s average trading volume, we note the 10-day average is 24.29 million shares, with the 3-month average coming to 14.87 million.
Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.29. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS was in red as seen at the end of in last trading. With action 21.79%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 246.63%, with the 5-day performance at 21.79% in the green. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is 63.83% up. Looking at the short shares, we see there were 39.52 million shares sold at short interest cover period of 2.17 days.
The consensus price target for the stock as assigned by Wall Street analysts is 23, meaning bulls need a downside of -34.13% from its current market value. According to analyst projections, HIMS’s forecast low is 8 with 38 as the target high. To hit the forecast high, the stock’s price needs a -23.18% plunge from its current level, while the stock would need to tank 74.07% for it to hit the projected low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Data shows that the Hims & Hers Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 50.56% over the past 6 months, a 600.00% in annual growth rate that is considerably higher than the industry average of 24.60%.
The 2024 estimates are for Hims & Hers Health Inc earnings to increase by 824.74%.
HIMS Dividends
Hims & Hers Health Inc is expected to release its next quarterly earnings report in January.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.39% of Hims & Hers Health Inc shares while 66.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 74.62%. There are 66.12% institutions holding the Hims & Hers Health Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 7.7166% of the shares, roughly 16.47 million HIMS shares worth $332.55 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30.
